New hope for early diagnosis and treatment of Parkinson's

Flinders University researchers have discovered that a protein in the brain may play a role in the development of Parkinson's disease – a common degenerative neurological disorder which affects the control of body movements.

The protein, known as VAMP2, is critical in communicating messages between brain cells, however Dr Wei-Ping Gai (pictured) from the University's Human Physiology Department says that it has also been found to induce cell death, possibly by aggregating inside brain cells.

The exact mechanisms by which the protein causes cell death is now being investigated by Dr Gai as part of a $15,000 research project funded through the FMC Foundation.

"VAMP2 is involved in but we recently discovered that it could be also involved in Parkinson's disease, we just don't know how it causes it or to what extent it's involved," Dr Gai, a research fellow and senior lecturer, said.

"In Parkinson's disease brain cells die and we think that dying process comes as a result of the protein aggregating inside these brain cells for some reason, leading to toxicity and, eventually, ," he said.

Using mass spectrometry, an analytical technique that determines the chemical structure of molecules, Dr Gai hopes to find out why the in brain cells, thereby paving the way for early diagnosis and targeted treatments for the debilitating disorder.

"At the moment there's no cure for Parkinson's disease because we only know die, we don't know exactly how they die or why the proteins aggregate," Dr Gai said.

"So if we can find out what causes these proteins to group together we might be able to find a cure or use the protein as a biomarker so that the disease can be detected much earlier than it currently is.

"Parkinson's is a terrible disease and it's often not detected until a late stage when the patient is already suffering many adverse consequences of the disorder, including tremors, and impaired mobility.

"It's the second most common neurodegenerative disorder in older populations and it's extremely prevalent in countries like Australia, which is why it must be a research priority."

Related Stories

Researchers visualize the development of Parkinson's cells

Jan 31, 2012

In the US alone, at least 500,000 people suffer from Parkinson's disease, a neurological disorder that affects a person's ability to control his or her movement. New technology from the University of Bonn in Germany lets ...

Molecular 'on-off' switch for Parkinson's disease discovered

May 23, 2012

(Medical Xpress) -- Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson's ...

Skin cells could help discover cause of Parkinson's disease

Jul 14, 2010

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease, the UK National Stem Cell Network (UKNSCN) annual science meeting ...

Recommended for you

EU team launches clinical trial of Parkinson's vaccine

Dec 09, 2014

Today the EU-consortium SYMPATH starts recruitment for a Phase I study of a Parkinson's vaccine candidate called AFFITOPE PD03A. This vaccine is one out of a designated pool of promising vaccine candidates based on AFFiRiS' ...

Weight and eating habits in Parkinson's disease

Nov 20, 2014

Patients affected by Parkinson's disease often show marked changes in body weight: they may gain or lose a lot of weight depending on the stage of the disease, or they may put on up to ten kilos after deep brain stimulation ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.